Business Wire

QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency

HILDEN, Germany & GERMANTOWN, Md,--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAstat-Dx Viral Vesicular Panel RUO, the first syndromic ...
Seeking Alpha

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha 1 - Antripsyn Deficiency (Alpha-1) in U.S. Adult Population BETHLEHEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE ...
Business Insider

Launch of New MolecuLightDX™ Device to Enable Point-of-Care Imaging of Wounds in New Expanding Market Segments

MolecuLight Platform is Becoming the Standard-of-Care for Real-Time Imaging of Elevated Bacterial Burden in Wounds Across All Wound Care Settings TORONTO, Oct. 14, 2021 /PRNewswire/ - MolecuLight Inc.
WREG

BIOTRONIK's DX Technology Reaches Significant Milestone: 100,000 DX Devices Implanted

Clinicians Recently Performed the 100,000th Procedure Implanting an ICD Equipped with DX Technology – the World's Only Single-Lead ICD System Providing Direct Atrial Sensing BERLIN, Jan. 29, 2024 ...
Morningstar

MolecuLight and DocNow Announce Integration for Seamless Data and Image Transfer for DX Devices

PITTSBURGH, April 29, 2025 /PRNewswire/ - MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an ...